Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry.
Hoeper MM, Pausch C, Grünig E, Klose H, Staehler G, Huscher D, Pittrow D, Olsson KM, Vizza CD, Gall H, Benjamin N, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Rosenkranz S, Ewert R, Kaemmerer H, Lange TJ, Kabitz HJ, Skowasch D, Skride A, Jureviciene E, Paleviciute E, Miliauskas S, Claussen M, Behr J, Milger K, Halank M, Wilkens H, Wirtz H, Pfeuffer-Jovic E, Harbaum L, Scholtz W, Dumitrescu D, Bruch L, Coghlan G, Neurohr C, Tsangaris I, Gorenflo M, Scelsi L, Vonk-Noordegraaf A, Ulrich S, Held M.
J Heart Lung Transplant. 2020 Dec;39(12):1435-1444. doi: 10.1016/j.healun.2020.09.011. Epub 2020 Sep 30.
Single-Cell Transcriptome Analysis of Peripheral Neutrophils From Patients With Idiopathic Pulmonary Arterial Hypertension.
Zhang R, Zhang J, Zhang YL, Gong SG, Zhao QH, Wang XJ, Zhao JY, Jiang R, Qiu HL, Li HT, He J, Liu SF, Kuebler WM, Wang L.
Hypertension. 2023 Aug;80(8):1784-1794. doi: 10.1161/HYPERTENSIONAHA.123.21142. Epub 2023 Jun 14.
Systemic Lupus Erythematosus and Pulmonary Hypertension.
Parperis K, Velidakis N, Khattab E, Gkougkoudi E, Kadoglou NPE.
Int J Mol Sci. 2023 Mar 7;24(6):5085. doi: 10.3390/ijms24065085.
Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?
Khan SL, Mathai SC.
Curr Opin Pulm Med. 2023 Sep 1;29(5):380-390. doi: 10.1097/MCP.0000000000001001. Epub 2023 Jul 14.
Phenotypes of idiopathic pulmonary arterial hypertension.
El-Kersh K, Nathan SD.
Lancet Respir Med. 2022 Oct;10(10):e88. doi: 10.1016/S2213-2600(22)00304-6.
Phenotypes of idiopathic pulmonary arterial hypertension.
Cruz-Utrilla A, Pérez-Olivares C, Martínez-Meñaca A, López-Meseguer M, Escribano-Subias P.
Lancet Respir Med. 2022 Oct;10(10):e87. doi: 10.1016/S2213-2600(22)00290-9.
Phenotypes of idiopathic pulmonary arterial hypertension.
Badagliacca R, Benza RL, Manzi G, Tello K, Naeije R.
Lancet Respir Med. 2022 Oct;10(10):e89. doi: 10.1016/S2213-2600(22)00308-3.
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension.
Marra AM, D'Agostino A, Salzano A, Basili S, D'Alto M, Bossone E, Cittadini A, Vizza CD, Badagliacca R.
Heart Fail Clin. 2023 Jan;19(1):115-123. doi: 10.1016/j.hfc.2022.09.001.
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity.
Favoino E, Prete M, Liakouli V, Leone P, Sisto A, Navarini L, Vomero M, Ciccia F, Ruscitti P, Racanelli V, Giacomelli R, Perosa F.
Autoimmun Rev. 2024 Apr;23(4):103514. doi: 10.1016/j.autrev.2024.103514. Epub 2024 Jan 3.
Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease.
Nathan SD.
Am J Respir Crit Care Med. 2023 Aug 1;208(3):238-246. doi: 10.1164/rccm.202212-2342CI.
